Drugs@FDA document

GLATOPA Letter · ANDA 206921 ORIG-1

Drugs@FDA document · SANDOZ · Feb 14, 2018

Key facts

Drug name GLATOPA
Document type Letter
Application ANDA206921
Submission ORIG-1
Company SANDOZ
Document date Feb 14, 2018
FDA document accessdata.fda.gov

At a glance

  • 1–9 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents